Algeta's IPO

Algeta raised a round of funding on March 26, 2007. Investors include Public.

Algeta is focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, based …

Articles about Algeta's IPO: